Predictmedix Inc. - Understand $pmedf stock

$PMEDF Market Cap: $1.503 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$1.516M

TTM

Current Assets

$83.29K

Q2 2024

Current Liabilities

$874.7K

Q2 2024

Current Ratio

9.52%

Q2 2024

Total Assets

$457.0K

Q2 2024

Total Liabilities

$874.7K

Q2 2024

Book Value

-$417.7K

Q2 2024

Cash

P/E

-0.9912

Nov 27, 2024 EST

Free Cash Flow

-$1.014M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Revenue	$0.00	$35.02K	$134.8K	$0.00	$0.00	$0.00	$4.226M	$5.309M	$7.196M	$3.465M	$1.695M
YoY Change	-100.0%	-74.02%					-20.4%	-26.22%	107.69%	104.42%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Revenue	$0.00	$35.02K	$134.8K	$0.00	$0.00	$0.00	$4.226M	$5.309M	$7.196M	$3.465M	$1.695M
Cost Of Revenue	$0.00	$8.400K	$50.00K				$3.095M	$4.526M	$4.196M	$2.657M	$2.705M
Gross Profit	$0.00	$26.62K	$84.82K				$1.131M	$783.0K	$3.001M	$808.0K	-$1.010M
Gross Profit Margin		76.01%	62.91%				26.77%	14.75%	41.7%	23.32%	-59.59%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Selling, General & Admin	$1.817M	$1.849M	$1.815M	$1.901M	$723.5K	$312.4K	$2.108M	$2.484M	$2.939M	$2.776M	$3.479M
YoY Change	-1.76%	1.91%	-4.53%	162.77%	131.61%		-15.17%	-15.46%	5.85%	-20.21%
% of Gross Profit		6947.6%	2139.63%				186.28%	317.28%	97.93%	343.56%
Research & Development		$82.60K	$72.89K	$26.30K	$73.73K	$49.21K
YoY Change		13.32%	177.15%	-64.33%	49.83%
% of Gross Profit		310.29%	85.93%
Depreciation & Amortization	$167.6K	$159.5K	$79.29K	$3.510K	$19.48K	$4.400K	$2.384M	$2.747M	$2.033M	$1.607M	$552.0K
YoY Change	5.12%	101.11%	2158.97%	-81.98%	342.73%		-13.24%	35.16%	26.5%	191.12%
% of Gross Profit		599.02%	93.48%				210.71%	350.88%	67.75%	198.89%
Operating Expenses	$1.984M	$2.092M	$1.967M	$1.931M	$816.7K	$366.0K	$4.491M	$5.232M	$4.971M	$3.734M	$4.145M
YoY Change	-5.12%	6.33%	1.87%	136.43%	123.16%		-14.15%	5.24%	33.14%	-9.92%
Operating Profit	-$1.984M	-$2.065M	-$1.882M				-$3.360M	-$4.449M	-$1.971M	-$2.926M	-$5.155M
YoY Change	-3.9%	9.71%					-24.47%	125.74%	-32.65%	-43.24%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2020	2019	2010	2009	2008	2007	2006
Interest Expense	-$9.020K	-$2.870K	0.000 cads	-$4.170K	$1.820K	-$8.578M	-$3.784M	-$8.426M	-$2.448M	-$415.0K
YoY Change	214.29%			-329.12%		126.69%	-55.09%	244.18%	489.88%
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Pretax Income	-$1.993M	-$2.068M	-$1.882M	-$1.931M	-$2.311M	-$364.1K	-$14.20M	-$8.233M	-$10.40M	-$5.374M	-$5.570M
YoY Change	-3.59%	9.86%	-2.52%	-16.45%	534.62%		72.44%	-20.81%	93.46%	-3.52%
Income Tax	$0.00						$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.993M	-$2.068M	-$1.882M	-$1.582M	-$2.292M	-$320.4K	-$14.20M	-$8.233M	-$10.40M	-$5.374M	-$5.570M
YoY Change	-3.59%	9.86%	19.0%	-30.98%	615.16%		72.44%	-20.81%	93.46%	-3.52%
Net Earnings / Revenue		-5904.51%	-1396.07%				-335.92%	-155.07%	-144.47%	-155.09%	-328.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$0.02	-$17.44K	-$15.63K	-$23.43K	-$5.585K	-$2.761M	-$2.002M	-$2.798M	-$1.472M	-$1.779M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Cash & Short-Term Investments	$36.87K	$79.25K	$211.3K	$480.1K	$1.494M	$1.559M	$88.79K	$18.05K	$583.7K	$20.00K	$102.0K
YoY Change	-53.48%	-62.49%	-55.98%	-67.86%	-4.19%		391.93%	-96.91%	2818.46%	-80.39%
Cash & Equivalents							$88.79K	$18.05K	$583.7K	$20.00K	$102.0K
Short-Term Investments
Other Short-Term Assets	$19.25K	$19.74K	$49.30K	$155.4K	$130.7K	$88.14K	$32.23K	$73.49K	$88.44K	$29.00K	$4.000K
YoY Change	-2.48%	-59.96%	-68.28%	18.96%	48.25%		-56.14%	-16.9%	204.96%	625.0%
Inventory
Prepaid Expenses
Receivables	$0.00	$12.51K	$169.6K				$138.0K	$921.8K	$2.963M	$816.0K	$773.0K
Other Receivables	$12.58K	$25.98K	$211.5K				$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$68.70K	$137.5K	$641.6K	$747.5K	$1.634M	$1.716M	$259.0K	$1.013M	$3.635M	$865.0K	$879.0K
YoY Change	-50.03%	-78.57%	-14.16%	-54.27%	-4.74%		-74.44%	-72.12%	320.21%	-1.59%
Property, Plant & Equipment	$94.18K	$134.6K	$76.26K	$8.190K	$32.38K	$14.11K	$1.950M	$67.88M	$60.66M	$43.99M	$36.80M
YoY Change	-30.0%	76.44%	831.14%	-74.71%	129.48%		-97.13%	11.9%	37.89%	19.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets							$0.00	$799.4K	$149.1K	$1.922M	$2.093M
YoY Change							-100.0%	436.2%	-92.24%	-8.17%
Total Long-Term Assets	$412.6K	$580.3K	$595.0K	$256.2K	$32.38K	$14.11K	$1.950M	$68.68M	$60.81M	$45.92M	$38.90M
YoY Change	-28.89%	-2.48%	132.27%	691.2%	129.48%		-97.16%	12.94%	32.44%	18.04%
Total Assets	$481.3K	$717.7K	$1.237M	$1.004M	$1.667M	$1.730M	$2.209M	$69.69M	$64.44M	$46.78M	$39.78M
YoY Change
Accounts Payable	$564.1K	$833.3K	$334.5K	$135.4K	$67.92K		$1.009M	$3.041M		$3.096M	$4.916M
YoY Change	-32.3%	149.14%	147.1%	99.28%			-66.82%			-37.02%
Accrued Expenses						$47.11K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$37.87K	$0.00	$0.00	$0.00	$0.00	$0.00	$406.1K	$0.00	$0.00	$0.00
YoY Change	-100.0%						-100.0%
Long-Term Debt Due				$0.00	$11.92K	$0.00	$46.23K	$9.036M	$4.692M	$2.231M	$405.0K
YoY Change				-100.0%			-99.49%	92.56%	110.32%	450.86%
Total Short-Term Liabilities	$625.2K	$871.1K	$349.7K	$135.4K	$79.84K	$47.11K	$997.5K	$12.31M	$8.568M	$5.327M	$5.321M
YoY Change	-28.24%	149.13%	158.35%	69.53%	69.48%		-91.9%	43.65%	60.85%	0.11%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$3.270K	$0.00	$57.40K	$40.27M	$32.82M	$16.17M	$4.877M
YoY Change				-100.0%			-99.86%	22.68%	102.99%	231.54%
Other Long-Term Liabilities							$72.48K	$2.064M	$2.309M	$467.0K	$434.0K
YoY Change							-96.49%	-10.62%	394.54%	7.6%
Total Long-Term Liabilities	$0.00	$0.00	$0.00	$0.00	$3.270K	$0.00	$129.9K	$42.33M	$35.13M	$16.64M	$5.311M
YoY Change				-100.0%			-99.69%	20.5%	111.18%	213.24%
Total Liabilities	$625.2K	$871.1K	$349.7K	$135.4K	$20.01K	$3.400K	$1.127M	$54.64M	$43.70M	$21.96M	$10.63M
YoY Change	-28.24%	149.13%	158.35%	576.41%	488.53%		-97.94%	25.04%	98.97%	106.57%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022	2021	2020	2019	2010	2009	2008	2007	2006
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.5026 Million

About Predictmedix Inc.

Predictmedix AI, Inc. operates as an artificial intelligence company. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. The company offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.

Industry: Services-Prepackaged Software Peers: